HiPPIP
Home
About
SZ Genes
People
Help
Advanced Search
CASP8 and BIRC6
Number of citations of the paper that reports this interaction (PubMedID
15507451
)
30
Data Source:
BioGRID
(enzymatic study)
CASP8
BIRC6
Description
caspase 8
baculoviral IAP repeat containing 6
Image
GO Annotations
Cellular Component
Nucleoplasm
Cytoplasm
Mitochondrion
Mitochondrial Outer Membrane
Cytosol
Cytoskeleton
Death-inducing Signaling Complex
CD95 Death-inducing Signaling Complex
Protein-containing Complex
Neuron Projection
Cell Body
Membrane Raft
Ripoptosome
Spindle Pole
Nucleus
Endosome
Trans-Golgi Network
Microtubule Organizing Center
Membrane
Midbody
Flemming Body
Molecular Function
Cysteine-type Endopeptidase Activity
Death Receptor Binding
Tumor Necrosis Factor Receptor Binding
Protein Binding
Peptidase Activity
Cysteine-type Peptidase Activity
Ubiquitin Protein Ligase Binding
Death Effector Domain Binding
Identical Protein Binding
Protein-containing Complex Binding
Scaffold Protein Binding
Cysteine-type Endopeptidase Activity Involved In Apoptotic Process
Cysteine-type Endopeptidase Activity Involved In Apoptotic Signaling Pathway
Cysteine-type Endopeptidase Activity Involved In Execution Phase Of Apoptosis
Ubiquitin-protein Transferase Activity
Cysteine-type Endopeptidase Inhibitor Activity
Protein Binding
Ubiquitin Conjugating Enzyme Activity
Biological Process
Angiogenesis
Regulation Of Cytokine Production
Proteolysis
Apoptotic Process
Activation Of Cysteine-type Endopeptidase Activity Involved In Apoptotic Process
Heart Development
Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors
Response To Cold
Regulation Of Tumor Necrosis Factor-mediated Signaling Pathway
Natural Killer Cell Activation
Macrophage Differentiation
Response To Cobalt Ion
Response To Estradiol
Response To Lipopolysaccharide
Positive Regulation Of Interleukin-1 Beta Production
Response To Tumor Necrosis Factor
TRAIL-activated Apoptotic Signaling Pathway
T Cell Activation
B Cell Activation
Positive Regulation Of Apoptotic Process
Positive Regulation Of I-kappaB Kinase/NF-kappaB Signaling
Negative Regulation Of I-kappaB Kinase/NF-kappaB Signaling
Regulation Of Innate Immune Response
Response To Ethanol
Positive Regulation Of Macrophage Differentiation
Positive Regulation Of Proteolysis
Response To Antibiotic
Proteolysis Involved In Cellular Protein Catabolic Process
Negative Regulation Of Necroptotic Process
Syncytiotrophoblast Cell Differentiation Involved In Labyrinthine Layer Development
Pyroptosis
Cellular Response To Mechanical Stimulus
Cellular Response To Organic Cyclic Compound
Apoptotic Signaling Pathway
Extrinsic Apoptotic Signaling Pathway
Execution Phase Of Apoptosis
Activation Of Cysteine-type Endopeptidase Activity
Self Proteolysis
Positive Regulation Of Neuron Death
Protein Phosphorylation
Ubiquitin-dependent Protein Catabolic Process
Apoptotic Process
Cell Cycle
Positive Regulation Of Cell Population Proliferation
Negative Regulation Of Endopeptidase Activity
Protein Ubiquitination
Regulation Of Cytokinesis
Regulation Of Cell Population Proliferation
Negative Regulation Of Apoptotic Process
Cell Division
Labyrinthine Layer Development
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway
Pathways
Apoptotic cleavage of cellular proteins
Caspase activation via Death Receptors in the presence of ligand
NOD1/2 Signaling Pathway
TRIF-mediated programmed cell death
Caspase-mediated cleavage of cytoskeletal proteins
Regulation by c-FLIP
RIPK1-mediated regulated necrosis
CASP8 activity is inhibited
TNFR1-induced proapoptotic signaling
Regulation of TNFR1 signaling
CLEC7A/inflammasome pathway
Regulation of necroptotic cell death
Dimerization of procaspase-8
Activation, myristolyation of BID and translocation to mitochondria
Apoptotic execution phase
FasL/ CD95L signaling
TRAIL signaling
TLR3-mediated TICAM1-dependent programmed cell death
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
Microbial modulation of RIPK1-mediated regulated necrosis
Defective RIPK1-mediated regulated necrosis
ALK mutants bind TKIs
Signaling by ALK fusions and activated point mutants
Drugs
Bryostatin 1
Bardoxolone
Diseases
GWAS
Basal cell carcinoma (
33549134
28177523
25855136
)
Breast cancer (
29059683
)
Chronic lymphocytic leukemia (
28165464
26956414
23770605
)
Cutaneous malignant melanoma (
32341527
)
Esophageal squamous cell carcinoma (
25129146
)
Lymphocyte counts (
27863252
)
Melanoma (
21983787
28212542
)
Multiple sclerosis (
31604244
)
Neutrophil percentage of white cells (
32888494
)
Nevus count or cutaneous melanoma (
32341527
30429480
)
Non-small cell lung cancer (
31326317
)
Plateletcrit (
32888494
)
Prostate cancer (
29892016
)
Rheumatoid arthritis (
30423114
24390342
)
Spleen volume (
34128465
)
White blood cell count (
32888494
)
Chronotype (
30696823
)
Coffee consumption (
31046077
)
General risk tolerance (MTAG) (
30643258
)
Male-pattern baldness (
28196072
)
Red cell distribution width (
32888494
)
Refractive error (
32231278
)
Risk-taking tendency (4-domain principal component model) (
30643258
)
Interacting Genes
140 interacting genes:
AGR3
ANGPTL4
AP1M1
APAF1
APP
AR
ATAD2
ATG4D
ATP1A3
BAP1
BCAP31
BCL2
BCL2L1
BCL2L10
BEX1
BFAR
BID
BIRC6
BLID
BMPR2
BRD1
CASC3
CASP1
CASP10
CASP14
CASP2
CASP3
CASP4
CASP6
CASP7
CASP8AP2
CASP9
CCNL1
CDH1
CDH13
CDK11B
CDKN1B
CFLAR
CHD3
CHUK
CNBP
COPS6
CRADD
CTNNB1
DDX5
DEDD
DEDD2
EDA2R
EIF2AK2
EPSTI1
ERBB4
ERRFI1
FADD
FAF1
FAS
FYN
GLCE
GMEB1
GREB1
GRIA1
GZMB
HBP1
HDAC7
HECTD3
HIP1
IFT57
IKBKB
IKBKG
IL13RA2
IL24
ILK
KLK5
KLK9
KRT18
LYPD3
MAP1LC3B
MAP3K14
MAP4K4
MAPK1
MAPK3
MAPT
NOD1
NOL3
NR1H4
NSD3
OGT
PARK7
PARP1
PARP2
PCYT1A
PDIA6
PEA15
PIAS1
PICALM
PIK3C3
PLA2G4B
PLEC
PLIN4
PRDM14
PRDX6
PRKCI
PRKCZ
PRKN
PRRX2
PRSS50
PSEN1
PSEN2
PSMC3IP
QDPR
RALBP1
RB1
RIPK1
RIPK2
RNF31
RYBP
S100A14
SCGB2A2
SERPINB5
SNRPD3
SNX19
SOX2
SRC
SRF
ST14
STK24
SUMO1
TFCP2
TNFRSF10A
TNFRSF10B
TOPORS
TRAF1
TRAF2
TRAF6
UBC
UMPS
USO1
VIM
VPS45
YBX1
ZNF707
23 interacting genes:
ALK
BIRC5
CASP3
CASP7
CASP8
CASP9
CDK1
CSNK2A1
DIABLO
EXOC3
EXOC4
GABARAP
HTRA2
MAP1LC3B
MAP2K1
PLK1
RAB8A
RACK1
RNF41
UBE2D1
USP8
VAV2
VCL
Entrez ID
841
57448
HPRD ID
03459
05731
Ensembl ID
ENSG00000064012
ENSG00000115760
Uniprot IDs
A0A024R3Z8
Q14790
Q9NR09
PDB IDs
1F9E
1I4E
1QDU
1QTN
2C2Z
2FUN
2K7Z
2Y1L
3H11
3KJN
3KJQ
4JJ7
4PRZ
4PS1
4ZBW
5H31
5H33
5JQE
5L08
6AGW
6PX9
3CEG
Enriched GO Terms of Interacting Partners
?
Tagcloud
?
Tagcloud (Difference)
?
Tagcloud (Intersection)
?